Correction to: Cell Discovery (2024) 10:12
https://doi.org/10.1038/s41421-023-00644-x published online 31 January 2024
In the initial publication of this article, we unintentionally misplaced an inaccurate image in Fig. 7a for the representative mice’s lungs H&E staining at day 35 post-injection of engineered MDA-MB-231 cells with doxycyclin treatment rescued with K334A BCAR3. The correct Fig. 7 is displayed as below. In addition, we stated in the methods section ‘Identification of methyl-sensitive binders’ that HeLa cells were used while the related experiments were performed with MDA-MB-231 cells.
These corrections neither affect the results nor the conclusion of this work. We apologize for any inconvenience these inadvertent errors might have caused.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Casanova, A.G., Roth, G.S., Hausmann, S. et al. Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis. Cell Discov 10, 34 (2024). https://doi.org/10.1038/s41421-024-00661-4
Published:
DOI: https://doi.org/10.1038/s41421-024-00661-4